OSCR

Programmed repair of disease-causing UGA premature termination codons in mammalian brain.

Overview

Authors: Ahmad Al Saneh1, Lionel Gissot1, Christopher A Ahern1
  1. Department of Molecular Physiology and Biophysics, University of Iowa, Iowa City, IA 52242, United States
Institutions: University of Iowa (United States)
Journal: Nucleic acids research, volume 54, issue 13, article gkag695
Dates: received 27 February 2026; accepted 1 June 2026; published online 16 July 2026; in print July 2026
Type: Research article · Language: English
License: CC BY
Identifiers: DOI 10.1093/nar/gkag695 · PMID 42460447 · PMCID PMC13373322 · OpenAlex W7169020288
Open access: gold, a free copy (OpenAlex)
Status: data only
Categories: human (organism), mouse (organism), clinical / translational (subfield)
MeSH: Brain*, Codon, Nonsense*, Codon, Terminator*, Genetic Therapy*, RNA, Transfer*, Animals, Dependovirus, Genetic Vectors, Humans, Mice (* major topic)
Topic: RNA and protein synthesis mechanisms (Molecular Biology, Biochemistry, Genetics and Molecular Biology), according to OpenAlex
Funding: NICHD NIH HHS (P50 HD103556); Simons Foundation (AR220030); Developmental Disabilities Research Center (P50HD103556); Simons Foundation Autism Research Initiative-Pilot Award (646844)
Citations: not cited yet (Europe PMC); 35 references in the paper
Research resources: 038165) with WT mice C57BL/6J mice RRID:IMSR_JAX:000

Abstract

Protein-truncating variants caused by stop codons are the most prevalent class of rare variant mutations in neurodevelopmental diseases, with UGA codons being most common. Suppressor transfer RNA (sup-tRNA) has therapeutic potential for premature termination codon (PTC) rescue but has thus far underperformed by traditional AAV delivery platforms, and progress has been hampered by the lack of methods to non-invasively assess in vivo activity in mammalian brain. To fill this material gap, we utilize transcranial in vivo bioluminescence imaging data from a luciferase-UGA mouse model to optimize viral payloads with sup-tRNA genes. These data demonstrate that U6 promoter-driven and single-stranded AAV2/9 constructs show variable and dose-dependent activity, whereas self-complementary AAV2/9 with the tRNA in a minimal 100-bp genomic context provides broad and efficacious PTC rescue. Further, payload tRNA multiplexing and use of tRNA introns enable efficacy of low viral titers and sustained rescue. tRNA sequencing of scAAV-delivered ArgUCA sup-tRNA in brain demonstrates no effects on endogenous tRNA levels, their acylation, or processing, and these features are also maintained in the delivered ArgUCA sup-tRNA. Collectively, this work defines a scalable strategy for precision UGA PTC stop codon suppression, supporting development of durable genetic rescue therapies for neurodevelopmental disorders in the mammalian brain.

Reproduced under the paper's license (CC BY), from the paper cited above.

Code

The paper links to its data, not to its authors' code: see the Data section.

The paper's code and data availability statement is in the Data section.

Tracing map

A tracing map links a paper to the code its authors published: this paper has none, so it has no map.

Data

Datasets cited

Other data links

Data availability

The tRNA sequencing data have been deposited in GEO (https://www.ncbi.nlm.nih.gov/geo/) under accession number GSE334212 (https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE334212). Custom scripts are available in the Supplementary Data. All relevant data are included within the article and its Supplementary Information files. Requests for further information and resources should be directed to and will be fulfilled by the lead contact, Christopher A. Ahern (E-mail: ).

Reproduced under the paper's license (CC BY), from the paper cited above.

Versions

The history of this record: each version stored by the harvester or made by a correction of its authors or of the maintainers of its code, and what changed in its facts. The texts of the paper (its abstract, its availability statements) are not part of it; versions that changed only those are not listed.

Version 1, 27 September 2026: the first record

Recorded: type, language, journal, volume, issue, pages, dates, 3 authors, 10 MeSH terms, 4 funders, 35 references, 1 RRID.

Cite

This paper

Al Saneh, A., Gissot, L., & Ahern, C. A. (2026). Programmed repair of disease-causing UGA premature termination codons in mammalian brain. Nucleic acids research, 54(13), gkag695. https://doi.org/10.1093/nar/gkag695

BibTeX

@article{alsaneh2026programmed,
author = {Al Saneh, Ahmad and Gissot, Lionel and Ahern, Christopher A},
title = {{Programmed repair of disease-causing UGA premature termination codons in mammalian brain}},
journal = {Nucleic acids research},
year = {2026},
month = jul,
volume = {54},
number = {13},
pages = {gkag695},
publisher = {Oxford University Press},
issn = {0305-1048},
doi = {10.1093/nar/gkag695},
url = {https://doi.org/10.1093/nar/gkag695},
pmid = {42460447},
pmcid = {PMC13373322}
}

RIS

TY - JOUR
AU - Al Saneh, Ahmad
AU - Gissot, Lionel
AU - Ahern, Christopher A
TI - Programmed repair of disease-causing UGA premature termination codons in mammalian brain
T2 - Nucleic acids research
J2 - Nucleic Acids Res
PY - 2026
DA - 2026/07/01
VL - 54
IS - 13
SP - gkag695
SN - 0305-1048
PB - Oxford University Press
DO - 10.1093/nar/gkag695
UR - https://doi.org/10.1093/nar/gkag695
LA - en
ER -

CSL-JSON

{
"id": "10.1093/nar/gkag695",
"type": "article-journal",
"title": "Programmed repair of disease-causing UGA premature termination codons in mammalian brain",
"container-title": "Nucleic acids research",
"author": [
{
"family": "Al Saneh",
"given": "Ahmad"
},
{
"family": "Gissot",
"given": "Lionel"
},
{
"family": "Ahern",
"given": "Christopher A"
}
],
"container-title-short": "Nucleic Acids Res",
"volume": "54",
"issue": "13",
"page": "gkag695",
"DOI": "10.1093/nar/gkag695",
"PMID": "42460447",
"PMCID": "PMC13373322",
"ISSN": "0305-1048",
"publisher": "Oxford University Press",
"URL": "https://doi.org/10.1093/nar/gkag695",
"language": "en",
"issued": {
"date-parts": [
[
2026,
7,
1
]
]
}
}

Similar papers

The papers with a page that share the most with this one: the tools found in their code, their categories, datasets, cited references and authors, the rarest counting most.

[1] doi:10.1038/s41392-026-02793-3
Engineered tRNA reduces vision loss in a mouse model of Leber congenital amaurosis.
Journal: Signal transduction and targeted therapy
In common: mouse, 11 references, 2 authors
[2] doi:10.1186/s13229-026-00716-1
Nitric oxide inhibition ameliorates cortical proteomic changes in the Cntnap2<sup>-/-</sup> and Shank3<sup>Δ4-22</sup> mouse models of autism spectrum disorder.
Journal: Molecular autism
In common: mouse, 1 reference
[3] doi:10.7554/elife.109104 [code]
Complementary vertebrate <i>Wac</i> models exhibit phenotypes relevant to DeSanto-Shinawi Syndrome.
Journal: eLife
In common: mouse, 1 reference
[4] doi:10.1186/s13293-026-00941-6
Prenatal BPA exposure perturbs RNA-binding protein-mediated splicing regulation and synaptogenesis in the developing cerebellum in a sex-dependent manner.
Journal: Biology of sex differences
In common: 1 reference

Contribute

The authors of this paper can claim it, correct its record and validate its tracing map, and the maintainers of its code (its owner, or a public member of its organization) correct what it says of their repository; anyone signed in can ask for its removal. Every request goes to OSCR's own machine, which answers it; your account page follows them.

Sign in with ORCID to claim this paper as one of its authors, correct its record or validate its tracing map: when the paper's metadata lists your ORCID iD, you are recognized at once. Maintainers of its code: sign in with GitHub, then claim the repository on your account page.

Request its removal

To ask OSCR to remove this record, the copies of its authors' scripts or its tracing map, use the removal request page: signed in, you say who you are, what to remove and why, then review and confirm the request. Published rules decide every request (how).

Discussion, reproductions, activity

Discussion: questions and error reports about this paper and its code, from signed-in readers and its authors. It opens with sign-in.

Reproductions: reports from readers who ran the authors' code: what they reproduced, with which environment, commit and data. It opens with sign-in.

Activity: what happens around this paper: new versions of its record, its map's validation, discussions and reproductions. It opens with sign-in.